Clinical Trial Highlights

UCSD IRB 200156, Utilization of Cervical Cancer Brachytherapy in San Diego and Imperial Counties, Principal Investigator: Jyoti Mayadev

UCSD IRB 200849, Investigation of Immune Correlates in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation on GOG 9929 (Prospective Phase I Trial), Co-principal investigator to use cervical cancer TR from the GOG 9929 phase I study, Principal Investigator: Jyoti Mayadev

UCSD IRB 800277, Quantifying Radiation Induced Vaginal Stenosis NCT05002751 Principal Investigator: Jyoti Mayadev

NRG GY-017: Phase I trial using anti PD-L1 (atezolizumab) as an immune primer and concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer; National Principal Investigator Jyoti Mayadev

CALLA: Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) (CALLA)

Principal Investigator Jyoti Mayadev